| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0885-3924(97)00371-0 |
| P698 | PubMed publication ID | 9601161 |
| P2093 | author name string | Meert T | |
| Awouters FH | |||
| Artois K | |||
| Megens AA | |||
| Vermeire J | |||
| P2860 | cites work | Transdermal fentanyl: acute analgesic clinical studies | Q35791397 |
| Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain | Q39466976 | ||
| Biotransformation of Neuroleptanalgesics | Q39943965 | ||
| Normalization of small intestinal propulsion with loperamide-like antidiarrheals in rats | Q43630181 | ||
| On the central sites for the antinociceptive action of morphine and fentanyl | Q48883196 | ||
| Transdermal fentanyl: a new step on the therapeutic ladder | Q51607880 | ||
| Potent, new analgesics, tailor-made for different purposes. | Q51860856 | ||
| A STUDY OF SOME OF THE PHARMACOLOGIC ACTIONS OF FENTANYL CITRATE. | Q52764703 | ||
| P433 | issue | 4 | |
| P921 | main subject | morphine | Q81225 |
| fentanyl | Q407541 | ||
| P304 | page(s) | 253-257 | |
| P577 | publication date | 1998-04-01 | |
| P1433 | published in | Journal of Pain and Symptom Management | Q6295708 |
| P1476 | title | Comparison of the analgesic and intestinal effects of fentanyl and morphine in rats | |
| P478 | volume | 15 |
| Q28255208 | A comparison of the antinociceptive and adverse effects of the mu-opioid agonist morphine and the delta-opioid agonist SNC80 |
| Q47166573 | Alterations in Rat Accumbens Endocannabinoid and GABA Content during Fentanyl Treatment: The Role of Ghrelin |
| Q42912140 | Antinociceptive effects and toxicity of morphine-6-O-sulfate sodium salt in rat models of pain |
| Q33834608 | Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl |
| Q42627025 | Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine. |
| Q48209130 | Distinct relations among plasma concentrations required for different pharmacological effects in oxycodone, morphine, and fentanyl |
| Q34536267 | Effect of fentanyl on 5-HT efflux involves both opioid and 5-HT1A receptors |
| Q36066043 | Emerging analgesics in cancer pain management |
| Q24203830 | Fentanyl for chronic pain |
| Q24242219 | Fentanyl for chronic pain |
| Q37809847 | Fentanyl sublingual: in breakthrough pain in opioid-tolerant adults with cancer |
| Q44515265 | Intravenous morphine can avoid distressing constipation associated with oral morphine: a retrospective analysis of our experience in 11 patients in the palliative care in-patient unit |
| Q52282252 | Is opiate compliance a problem in cancer pain? A survey of health-care professionals' views. |
| Q46950147 | Is the use of transdermal fentanyl inappropriate according to the WHO guidelines and the EAPC recommendations? A study of cancer patients in Italy |
| Q24648711 | Morphine and alternative opioids in cancer pain: the EAPC recommendations |
| Q42702299 | Morphine-Induced Constipation Develops With Increased Aquaporin-3 Expression in the Colon via Increased Serotonin Secretion |
| Q42657899 | Opioid purchases and expenditure in nine western European countries: 'are we killing off morphine?'. |
| Q91828504 | Oxycodone, fentanyl, and morphine amplify established neuropathic pain in male rats |
| Q34761368 | Palliative care of the chronically critically ill patient |
| Q60673767 | Pharmacology of opioid analgesia: clinical principles |
| Q28364765 | Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain |
| Q44353030 | Reduction in constipation and laxative requirements following opioid rotation to methadone: a report of four cases |
| Q31032026 | Simultaneous determination of prochlorperazine and its metabolites in human plasma using isocratic liquid chromatography tandem mass spectrometry |
| Q34297489 | Strategies for the treatment of cancer pain in the new millennium |
| Q44789142 | Strong opioids and constipation |
| Q80967273 | Successful use of transdermal fentanyl in patients with cancers of the prostate, ovary and stomach |
| Q36279466 | The role of opioids in cancer pain |
| Q48672918 | Toward evidence-based prescribing at end of life: a comparative analysis of sustained-release morphine, oxycodone, and transdermal fentanyl, with pain, constipation, and caregiver interaction outcomes in hospice patients |
| Q34481299 | Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control |
| Q80967277 | Use of transdermal fentanyl in cancer patients with intestinal problems: four case studies |
| Q56562347 | Window of opportunity for pain control in the terminally ill |
Search more.